REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Gal es Tarsai Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: GAL es TARSAI Gyogyszer-kiskereskedelmi Bt. Profile Updated: November 23, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Gal es Tarsai Bt. is based in Hungary, with the head office in Jaszladany. It operates in the Pharmacies and Drug Stores industry. The company was established on October 18, 1993. 4 (2024) employees currently work for Gal es Tarsai Bt.. In 2023, the company reported a net sales revenue increase of 6.93%. Its’ total assets recorded a growth of 9.2%. Gal es Tarsai Bt.’s net profit margin increased by 0.91% in 2023.

Headquarters
Kossuth L. u. 87.
Jaszladany; Jasz-Nagykun-Szolnok; Postal Code: 5055

Contact Details: Purchase the Gal es Tarsai Bt. report to view the information.

Basic Information
Total Employees:
Purchase the Gal es Tarsai Bt. report to view the information.
Outstanding Shares:
Purchase the Gal es Tarsai Bt. report to view the information.
Registered Capital:
Purchase the Gal es Tarsai Bt. report to view the information.
Financial Auditors:
Purchase the Gal es Tarsai Bt. report to view the information.
Incorporation Date:
October 18, 1993
Key Executives
Purchase this report to view the information.
Executive Officer
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Gal es Tarsai Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
6.93%▲
Total operating revenue
6.81%▲
Operating profit (EBIT)
45.15%▲
EBITDA
32.06%▲
Net Profit (Loss) for the Period
124.01%▲
Total assets
9.2%▲
Total equity
7.79%▲
Operating Profit Margin (ROS)
0.48%▲
Net Profit Margin
0.91%▲
Return on Equity (ROE)
3.75%▲
Quick Ratio
-0.59%▼
Cash Ratio
-0.17%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo